COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab

Vaccines will play a key role in ending the COVID-19 pandemic. Vaccination against infections remains an important part of the management of patients with multiple sclerosis. However, there are limited data about the safety and efficacy of the currently available COVID-19 mRNA vaccines in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilimuri, Sridhar, Mantri, Nikhitha, Gongati, Sudharsan, Zahid, Maleeha, Sun, Haozhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002140/
https://www.ncbi.nlm.nih.gov/pubmed/33806646
http://dx.doi.org/10.3390/vaccines9030219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002140/
https://www.ncbi.nlm.nih.gov/pubmed/33806646
http://dx.doi.org/10.3390/vaccines9030219

Ejemplares similares